On this page we presented the RNAC PE Ratio History information for Cartesian Therapeutics' stock. The average RNAC PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 261.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RNAC PE ratio history based on this TTM earnings result method is 393.6. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RNAC PE ratio history result, against the recent PE: when this page was posted on 4/22/2024, the most recent closing price for RNAC had been 18.26, and the most recent quarterly earnings result, annualized, was 0.16. Meanwhile, the most recent TTM earnings summed to 0.13. From these numbers, we calculate the recent RNAC PE on 4/22/2024 based on annualized quarterly EPS was 114.1. Based on RNAC's history, that recent PE is low relative to the historical average, with the recent PE 56.3% lower than the historical average PE across our data set for Cartesian Therapeutics. Looking at the recent RNAC PE on 4/22/2024 based on TTM EPS, we calculate the ratio at 140.5. Based on RNAC's history, that recent PE is low relative to the historical average, with the recent PE 64.3% lower than the average PE across our Cartesian Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on RNAC or any other given stock, valuation analysis for RNAC can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cartesian Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for RNAC. Thanks for visiting, and the next time you need to research RNAC PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.